Who makes 5%Povidone Iodine- 69%Ethanol?

5%Povidone Iodine- 69%Ethanol is developed by Poitiers University Hospital.

What development phase is 5%Povidone Iodine- 69%Ethanol in?

5%Povidone Iodine- 69%Ethanol is FDA-approved (marketed).

Last reviewed 2026-05-15 · How we verify

5%Povidone Iodine- 69%Ethanol

Poitiers University Hospital · FDA-approved active Small molecule Quality 0/100

5% Povidone Iodine-69% Ethanol is a marketed antiseptic solution developed by Poitiers University Hospital, currently holding a position in the antiseptic market. The key composition patent, set to expire in 2028, provides a competitive advantage by protecting the unique formulation. The primary risk is the potential increase in competition following the patent expiry, which could erode market share.

At a glance

Generic name	5%Povidone Iodine- 69%Ethanol
Sponsor	Poitiers University Hospital
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Randomized Trial of 2% Chlorhexidine-70% Isopropanol vs 5% Povidone Iodine-69% Ethanol for Skin Antisepsis in Reducing Surgical-site Infection After Cardiac Surgery (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

5%Povidone Iodine- 69%Ethanol CI brief — competitive landscape report
5%Povidone Iodine- 69%Ethanol updates RSS · CI watch RSS
Poitiers University Hospital portfolio CI